Neoadjuvant Oncolytic Virotherapy for Recurrent Breast Cancer
Anirban Maitra, Professor of Pathology and Translational Molecular Pathology at UT MD Anderson Cancer Center, shared a recent article by Beata Halassy on X:
“Virologist Beata Halassy treated her own recurrent Breast Cancer with two independent strains of oncolytic viruses and is currently cancer free 4 years later. She published her case report in Vaccines MDPI.”
Read about Halassy’s experiment.
Title: An Unconventional Case Study of Neoadjuvant Oncolytic Virotherapy for Recurrent Breast Cancer
Authors: Dubravko Forčić, Karmen Mršić, Melita Perić-Balja, Tihana Kurtović, Snježana Ramić,Tajana Silovski, Ivo Pedišić, Ivan Milas and Beata Halassy
Dr. Anirban Maitra serves as Professor of Pathology and Translational Molecular Pathology at UT MD Anderson Cancer Center since August 2013 and directs the Sheikh Ahmed Pancreatic Cancer Research Center. He leads an NCI-funded laboratory dedicated to pancreatic cancer research, focusing on genetics and molecular pathology in human and mouse models. His research aims to advance early detection and interception strategies to enhance patient survival rates in pancreatic cancer.
More posts featuring Anirban Maitra.
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023